Davies Financial Advisors Inc. Has $867,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Davies Financial Advisors Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,714 shares of the healthcare conglomerate’s stock after selling 198 shares during the period. Davies Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $867,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. M&T Bank Corp boosted its holdings in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after acquiring an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its position in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. lifted its position in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares in the last quarter. Parsifal Capital Management LP bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $21,165,000. Finally, Signal Advisors Wealth LLC boosted its position in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $510.03 on Tuesday. The business has a 50-day simple moving average of $549.37 and a 200 day simple moving average of $563.70. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $5.83 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

A number of research firms have recently commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.